Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	2019 - 2015
Period Ending	Oct '24 Oct 15, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	361	336	1,655	1,692	2,051	355	Upgrade
Market Cap Growth	-26.13%	-79.72%	-2.19%	-17.53%	477.70%	28.87%	Upgrade
Enterprise Value	-225	-33	1,094	1,382	1,810	214	Upgrade
Last Close Price	8.87	8.20	38.83	40.80	63.30	13.77	Upgrade
PE Ratio	-	16.62	-11.75	-13.91	-25.28	-4.76	Upgrade
PS Ratio	-	69.54	174.08	200.54	236.73	40.73	Upgrade
PB Ratio	0.59	0.57	3.11	3.26	5.49	-	Upgrade
P/FCF Ratio	-67.41	-8.83	-16.56	-16.29	-29.68	-4.29	Upgrade
P/OCF Ratio	-69.06	-9.05	-16.85	-16.30	-30.21	-4.46	Upgrade
EV/Sales Ratio	-	-6.93	115.15	163.83	208.87	24.59	Upgrade
EV/EBITDA Ratio	3.36	0.60	-7.68	-12.03	-23.38	-2.94	Upgrade
EV/EBIT Ratio	3.31	0.59	-7.67	-12.02	-23.31	-2.94	Upgrade
EV/FCF Ratio	38.53	0.88	-10.95	-13.31	-26.19	-2.59	Upgrade
Debt / Equity Ratio	0.00	0.32	0.01	0.00	0.00	-	Upgrade
Debt / FCF Ratio	-0.31	-4.89	-0.03	-0.01	-0.02	-	Upgrade
Asset Turnover	-	0.01	0.02	-	0.03	-	Upgrade
Quick Ratio	40.92	3.05	27.10	19.85	14.09	-	Upgrade
Current Ratio	41.06	3.06	27.34	20.08	14.27	-	Upgrade
Return on Equity (ROE)	12.70%	3.24%	-23.77%	-	-30.78%	-	Upgrade
Return on Assets (ROA)	-4.72%	-5.16%	-14.95%	-	-17.54%	-	Upgrade
Return on Capital (ROIC)	-4.90%	-5.38%	-15.90%	-	-20.19%	-	Upgrade
Earnings Yield	19.98%	5.93%	-7.77%	-6.44%	-3.48%	-19.89%	Upgrade
FCF Yield	-1.48%	-11.32%	-6.04%	-6.14%	-3.37%	-23.31%	Upgrade
Buyback Yield / Dilution	-3.79%	-4.02%	-5.08%	-30.36%	-16.71%	-18.81%	Upgrade
Total Shareholder Return	-3.79%	-4.02%	-5.08%	-30.36%	-16.71%	-18.81%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.